ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

ARS Pharma gets FDA approval for epinephrine nasal spray neffy, the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions.

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...

An April 2024 report from Safer Tourism Foundation finds 12% of travelers reported a food-related allergic reaction while on ...

A Massachusetts man said the sting of an Asian needle ant left him feeling sick. The invasive insect has been spreading ...

If you ignore the severity of this medical condition, it’s as bad as shoving a loaded gun in my face,” she said in a video shared with her fans.

For individuals with type 1 diabetes – an autoimmune condition – maintaining stable blood sugar is a constant challenge.

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

For people with type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

Jo Frost’s powerful message about living with a serious health condition is a reminder to show more compassion.

US researchers have developed a tiny implantable device that automatically releases glucagon to prevent life-threatening low blood sugar in Type 1 diabetics, eliminating the need for emergency ...

Traveler Dan Kelly faced criticism after requesting that other passengers refrain from eating snacks containing nuts due to ...